• Food
  • Fitness
  • Wellness
  • Parenting
  • Vital Signs
Edition
  • U.S.
  • International
  • Arabic
  • Español
  • Food
  • Fitness
  • Wellness
  • Parenting
  • Vital Signs
Edition
  • U.S.
  • International
  • Arabic
  • Español
  • World
    • Africa
    • Americas
    • Asia
    • Australia
    • China
    • Europe
    • India
    • Middle East
    • United Kingdom
  • US Politics
    • 2020 Election
    • Facts First
    • Election 101
  • Business
    • Markets
    • Tech
    • Media
    • Success
    • Perspectives
    • Videos
  • Health
    • Food
    • Fitness
    • Wellness
    • Parenting
    • Vital Signs
  • Entertainment
    • Stars
    • Screen
    • Binge
    • Culture
    • Media
  • Tech
    • Innovate
    • Gadget
    • Foreseeable Future
    • Mission: Ahead
    • Upstarts
    • Work Transformed
    • Innovative Cities
  • Style
    • Arts
    • Design
    • Fashion
    • Architecture
    • Luxury
    • Beauty
    • Video
  • Travel
    • Destinations
    • Food and Drink
    • Stay
    • News
    • Videos
  • Sports
    • Football
    • Tennis
    • Equestrian
    • Golf
    • Skiing
    • Horse Racing
    • Motorsport
    • Formula E
    • Esports
  • Videos
    • Live TV
    • Digital Studios
    • CNN Films
    • HLN
    • TV Schedule
    • TV Shows A-Z
    • CNNVR
  • Features
    • Call to Earth
    • Freedom Project
    • Impact Your World
    • Inside Africa
    • 2 Degrees
    • CNN Heroes
    • All Features
  • More
    • Photos
    • Longform
    • Investigations
    • CNN Profiles
    • CNN Leadership
    • CNN Newsletters
    • Work for CNN
  • Weather
    • Climate
    • Storm Tracker
    • Video
Follow CNN
  • Patients suffering from renal failure receive hemodialysis treatment at a clinic in Barquisimeto, Venezuela, on April 24, 2019. - For cronic patients humanitarian aid is still far away. The fist stage of the aid is expected to last a year and will assist 650,000 people. Medicines for cronic patients are contemplated in a second stage. (Photo by YURI CORTEZ / AFP) (Photo credit should read YURI CORTEZ/AFP/Getty Images)

    Fewer than 10% in the US have antibodies to the novel coronavirus

  • With AstraZeneca's vaccine trial still on pause in US, questions abound about study participants' mysterious illnesses

  • By August, 1 in 5 Covid-19 cases was someone in their 20s

  • FDA considering authorization rules that could push coronavirus vaccine past Election Day

  • CDC abruptly removes guidance about airborne coronavirus transmission, says update 'was posted in error'

    Latest

  • How climate change affects pandemics

  • New York City's spike in cases shows coronavirus is still 'a force to be reckoned with,' governor says

  • 1 in 3 parents won't get flu shots for their child during Covid-19, study finds

  • Post-Covid clinics get jump-start from patients with lingering illness